BD HorizonTM V450 Mouse Anti-Human HLA-DR

Description

Flow cytometric analysis of HLA-DR expression on human peripheral blood lymphocytes. Whole blood was stained with either BD Horizon V450 Mouse anti-Human HLA-DR antibody Cat. No. 561359; solid line histogram or with a BD Horizon V450 Mouse IgG2a, kappa Isotype Control Cat. No. 560550; dashed line histogram . The erythrocytes were lysed with BD PharmLyse Lysing Buffer Cat. No. 555899 . The fluorescence histograms were derived from events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD LSR II Flow Cytometer System. Flow cytometric analysis of HLA-DR expression on human peripheral blood lymphocytes. Whole blood was stained with either BD Horizon V450 Mouse anti-Human HLA-DR antibody Cat. No. 561359; solid line histogram or with a BD Horizon V450 Mouse IgG2a, kappa Isotype Control Cat. No. 560550; dashed line histogram . The erythrocytes were lysed with BD PharmLyse Lysing Buffer Cat. No. 555899 . The fluorescence histograms were derived from events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD LSR II Flow Cytometer System. Show More Flow cytometric analysis of HLA-DR expression on human peripheral blood lymphocytes. Whole blood was stained with either BD Horizon V450 Mouse anti-Human HLA-DR antibody Cat. No. 561359; solid line histogram or with a BD Horizon V450 Mouse IgG2a, kappa Isotype Control Cat. No. 560550; dashed line histogram . The erythrocytes were lysed with BD PharmLyse Lysing Buffer Cat. No. 555899 . The fluorescence histograms were derived from events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD LSR II Flow Cytometer System.